Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer have?
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer has 45 citations in the OpenAlex counts ScholarIQ stores.
When was Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer published?
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer has 2022 year in the ScholarIQ index.
What is the open-access status of Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer?
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer has gold oa status in the ScholarIQ index.
What is the DOI of Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer?
The DOI for Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer is on the source record.
What is the PMID of Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer?
The PMID for Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer is on the source record.
What is the OpenAlex record for Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer?
The OpenAlex for Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer is on the source record.